Category: Pharma

Direction of the USPTO in 2021
Read More
2017 in Review: Part Two
Read More
Allergan Patent Controversy Continues
Read More
WIPO & Pharma Team-Up with Pat-INFORMED Program
Read More
Allergan Strikes Unconventional Deal to Protect Patents
Read More
FluMist Flop: CDC Finds Inventive Vaccine Ineffective
Read More
Mylan Pharmaceuticals Under Fire for EpiPen Price Jump
Read More
Pharma Patents & The Battle of Brand V. Generic
Read More
GSK Announces New “Graduated” Approach to Patents
Read More
Pfizer Settles Seven Year Lawsuit with $784 Million
Read More
WTO Extends Waiver on Patents for LDCs
Read More
New Cure for Hepatitis C: Patent Litigation & High Price
Read More